Global HER2 Targeted Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global HER2 Targeted Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the HER2 Targeted Therapy industry chain, the market status of Breast Cancer (Monotherapy, Combination Therapy), Stomach Cancer (Monotherapy, Combination Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of HER2 Targeted Therapy.

Regionally, the report analyzes the HER2 Targeted Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global HER2 Targeted Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the HER2 Targeted Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the HER2 Targeted Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monotherapy, Combination Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the HER2 Targeted Therapy market.

Regional Analysis: The report involves examining the HER2 Targeted Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the HER2 Targeted Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to HER2 Targeted Therapy:
Company Analysis: Report covers individual HER2 Targeted Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards HER2 Targeted Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Breast Cancer, Stomach Cancer).

Technology Analysis: Report covers specific technologies relevant to HER2 Targeted Therapy. It assesses the current state, advancements, and potential future developments in HER2 Targeted Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the HER2 Targeted Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
HER2 Targeted Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Monotherapy
    Combination Therapy
    Others

Market segment by Application
    Breast Cancer
    Stomach Cancer
    Head and Neck Cancer
    Lung Cancer
    Ovarian Cancer
    Others

Market segment by players, this report covers
    GlaxoSmithKline
    Bayer
    Abbott
    AbbVie
    Pfizer
    Sanofi
    Agilent
    Glenmark Pharmaceuticals
    Merck
    Roche
    Novartis
    Astra Zeneca
    Daiichi Sankyo

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe HER2 Targeted Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of HER2 Targeted Therapy, with revenue, gross margin and global market share of HER2 Targeted Therapy from 2019 to 2024.
Chapter 3, the HER2 Targeted Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and HER2 Targeted Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of HER2 Targeted Therapy.
Chapter 13, to describe HER2 Targeted Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of HER2 Targeted Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of HER2 Targeted Therapy by Type
        1.3.1 Overview: Global HER2 Targeted Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global HER2 Targeted Therapy Consumption Value Market Share by Type in 2023
        1.3.3 Monotherapy
        1.3.4 Combination Therapy
        1.3.5 Others
    1.4 Global HER2 Targeted Therapy Market by Application
        1.4.1 Overview: Global HER2 Targeted Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Breast Cancer
        1.4.3 Stomach Cancer
        1.4.4 Head and Neck Cancer
        1.4.5 Lung Cancer
        1.4.6 Ovarian Cancer
        1.4.7 Others
    1.5 Global HER2 Targeted Therapy Market Size & Forecast
    1.6 Global HER2 Targeted Therapy Market Size and Forecast by Region
        1.6.1 Global HER2 Targeted Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global HER2 Targeted Therapy Market Size by Region, (2019-2030)
        1.6.3 North America HER2 Targeted Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe HER2 Targeted Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific HER2 Targeted Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America HER2 Targeted Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa HER2 Targeted Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 GlaxoSmithKline
        2.1.1 GlaxoSmithKline Details
        2.1.2 GlaxoSmithKline Major Business
        2.1.3 GlaxoSmithKline HER2 Targeted Therapy Product and Solutions
        2.1.4 GlaxoSmithKline HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 GlaxoSmithKline Recent Developments and Future Plans
    2.2 Bayer
        2.2.1 Bayer Details
        2.2.2 Bayer Major Business
        2.2.3 Bayer HER2 Targeted Therapy Product and Solutions
        2.2.4 Bayer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Bayer Recent Developments and Future Plans
    2.3 Abbott
        2.3.1 Abbott Details
        2.3.2 Abbott Major Business
        2.3.3 Abbott HER2 Targeted Therapy Product and Solutions
        2.3.4 Abbott HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Abbott Recent Developments and Future Plans
    2.4 AbbVie
        2.4.1 AbbVie Details
        2.4.2 AbbVie Major Business
        2.4.3 AbbVie HER2 Targeted Therapy Product and Solutions
        2.4.4 AbbVie HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 AbbVie Recent Developments and Future Plans
    2.5 Pfizer
        2.5.1 Pfizer Details
        2.5.2 Pfizer Major Business
        2.5.3 Pfizer HER2 Targeted Therapy Product and Solutions
        2.5.4 Pfizer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Pfizer Recent Developments and Future Plans
    2.6 Sanofi
        2.6.1 Sanofi Details
        2.6.2 Sanofi Major Business
        2.6.3 Sanofi HER2 Targeted Therapy Product and Solutions
        2.6.4 Sanofi HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Sanofi Recent Developments and Future Plans
    2.7 Agilent
        2.7.1 Agilent Details
        2.7.2 Agilent Major Business
        2.7.3 Agilent HER2 Targeted Therapy Product and Solutions
        2.7.4 Agilent HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Agilent Recent Developments and Future Plans
    2.8 Glenmark Pharmaceuticals
        2.8.1 Glenmark Pharmaceuticals Details
        2.8.2 Glenmark Pharmaceuticals Major Business
        2.8.3 Glenmark Pharmaceuticals HER2 Targeted Therapy Product and Solutions
        2.8.4 Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Glenmark Pharmaceuticals Recent Developments and Future Plans
    2.9 Merck
        2.9.1 Merck Details
        2.9.2 Merck Major Business
        2.9.3 Merck HER2 Targeted Therapy Product and Solutions
        2.9.4 Merck HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Merck Recent Developments and Future Plans
    2.10 Roche
        2.10.1 Roche Details
        2.10.2 Roche Major Business
        2.10.3 Roche HER2 Targeted Therapy Product and Solutions
        2.10.4 Roche HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Roche Recent Developments and Future Plans
    2.11 Novartis
        2.11.1 Novartis Details
        2.11.2 Novartis Major Business
        2.11.3 Novartis HER2 Targeted Therapy Product and Solutions
        2.11.4 Novartis HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Novartis Recent Developments and Future Plans
    2.12 Astra Zeneca
        2.12.1 Astra Zeneca Details
        2.12.2 Astra Zeneca Major Business
        2.12.3 Astra Zeneca HER2 Targeted Therapy Product and Solutions
        2.12.4 Astra Zeneca HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Astra Zeneca Recent Developments and Future Plans
    2.13 Daiichi Sankyo
        2.13.1 Daiichi Sankyo Details
        2.13.2 Daiichi Sankyo Major Business
        2.13.3 Daiichi Sankyo HER2 Targeted Therapy Product and Solutions
        2.13.4 Daiichi Sankyo HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Daiichi Sankyo Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global HER2 Targeted Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of HER2 Targeted Therapy by Company Revenue
        3.2.2 Top 3 HER2 Targeted Therapy Players Market Share in 2023
        3.2.3 Top 6 HER2 Targeted Therapy Players Market Share in 2023
    3.3 HER2 Targeted Therapy Market: Overall Company Footprint Analysis
        3.3.1 HER2 Targeted Therapy Market: Region Footprint
        3.3.2 HER2 Targeted Therapy Market: Company Product Type Footprint
        3.3.3 HER2 Targeted Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global HER2 Targeted Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global HER2 Targeted Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global HER2 Targeted Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global HER2 Targeted Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America HER2 Targeted Therapy Consumption Value by Type (2019-2030)
    6.2 North America HER2 Targeted Therapy Consumption Value by Application (2019-2030)
    6.3 North America HER2 Targeted Therapy Market Size by Country
        6.3.1 North America HER2 Targeted Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico HER2 Targeted Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe HER2 Targeted Therapy Consumption Value by Type (2019-2030)
    7.2 Europe HER2 Targeted Therapy Consumption Value by Application (2019-2030)
    7.3 Europe HER2 Targeted Therapy Market Size by Country
        7.3.1 Europe HER2 Targeted Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        7.3.3 France HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy HER2 Targeted Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific HER2 Targeted Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific HER2 Targeted Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific HER2 Targeted Therapy Market Size by Region
        8.3.1 Asia-Pacific HER2 Targeted Therapy Consumption Value by Region (2019-2030)
        8.3.2 China HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        8.3.5 India HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia HER2 Targeted Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America HER2 Targeted Therapy Consumption Value by Type (2019-2030)
    9.2 South America HER2 Targeted Therapy Consumption Value by Application (2019-2030)
    9.3 South America HER2 Targeted Therapy Market Size by Country
        9.3.1 South America HER2 Targeted Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina HER2 Targeted Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa HER2 Targeted Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa HER2 Targeted Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa HER2 Targeted Therapy Market Size by Country
        10.3.1 Middle East & Africa HER2 Targeted Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia HER2 Targeted Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE HER2 Targeted Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 HER2 Targeted Therapy Market Drivers
    11.2 HER2 Targeted Therapy Market Restraints
    11.3 HER2 Targeted Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 HER2 Targeted Therapy Industry Chain
    12.2 HER2 Targeted Therapy Upstream Analysis
    12.3 HER2 Targeted Therapy Midstream Analysis
    12.4 HER2 Targeted Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global HER2 Targeted Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global HER2 Targeted Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global HER2 Targeted Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global HER2 Targeted Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 6. GlaxoSmithKline Major Business
    Table 7. GlaxoSmithKline HER2 Targeted Therapy Product and Solutions
    Table 8. GlaxoSmithKline HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. GlaxoSmithKline Recent Developments and Future Plans
    Table 10. Bayer Company Information, Head Office, and Major Competitors
    Table 11. Bayer Major Business
    Table 12. Bayer HER2 Targeted Therapy Product and Solutions
    Table 13. Bayer HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Bayer Recent Developments and Future Plans
    Table 15. Abbott Company Information, Head Office, and Major Competitors
    Table 16. Abbott Major Business
    Table 17. Abbott HER2 Targeted Therapy Product and Solutions
    Table 18. Abbott HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Abbott Recent Developments and Future Plans
    Table 20. AbbVie Company Information, Head Office, and Major Competitors
    Table 21. AbbVie Major Business
    Table 22. AbbVie HER2 Targeted Therapy Product and Solutions
    Table 23. AbbVie HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. AbbVie Recent Developments and Future Plans
    Table 25. Pfizer Company Information, Head Office, and Major Competitors
    Table 26. Pfizer Major Business
    Table 27. Pfizer HER2 Targeted Therapy Product and Solutions
    Table 28. Pfizer HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Pfizer Recent Developments and Future Plans
    Table 30. Sanofi Company Information, Head Office, and Major Competitors
    Table 31. Sanofi Major Business
    Table 32. Sanofi HER2 Targeted Therapy Product and Solutions
    Table 33. Sanofi HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Sanofi Recent Developments and Future Plans
    Table 35. Agilent Company Information, Head Office, and Major Competitors
    Table 36. Agilent Major Business
    Table 37. Agilent HER2 Targeted Therapy Product and Solutions
    Table 38. Agilent HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Agilent Recent Developments and Future Plans
    Table 40. Glenmark Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 41. Glenmark Pharmaceuticals Major Business
    Table 42. Glenmark Pharmaceuticals HER2 Targeted Therapy Product and Solutions
    Table 43. Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Glenmark Pharmaceuticals Recent Developments and Future Plans
    Table 45. Merck Company Information, Head Office, and Major Competitors
    Table 46. Merck Major Business
    Table 47. Merck HER2 Targeted Therapy Product and Solutions
    Table 48. Merck HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Merck Recent Developments and Future Plans
    Table 50. Roche Company Information, Head Office, and Major Competitors
    Table 51. Roche Major Business
    Table 52. Roche HER2 Targeted Therapy Product and Solutions
    Table 53. Roche HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Roche Recent Developments and Future Plans
    Table 55. Novartis Company Information, Head Office, and Major Competitors
    Table 56. Novartis Major Business
    Table 57. Novartis HER2 Targeted Therapy Product and Solutions
    Table 58. Novartis HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Novartis Recent Developments and Future Plans
    Table 60. Astra Zeneca Company Information, Head Office, and Major Competitors
    Table 61. Astra Zeneca Major Business
    Table 62. Astra Zeneca HER2 Targeted Therapy Product and Solutions
    Table 63. Astra Zeneca HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Astra Zeneca Recent Developments and Future Plans
    Table 65. Daiichi Sankyo Company Information, Head Office, and Major Competitors
    Table 66. Daiichi Sankyo Major Business
    Table 67. Daiichi Sankyo HER2 Targeted Therapy Product and Solutions
    Table 68. Daiichi Sankyo HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Daiichi Sankyo Recent Developments and Future Plans
    Table 70. Global HER2 Targeted Therapy Revenue (USD Million) by Players (2019-2024)
    Table 71. Global HER2 Targeted Therapy Revenue Share by Players (2019-2024)
    Table 72. Breakdown of HER2 Targeted Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 73. Market Position of Players in HER2 Targeted Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 74. Head Office of Key HER2 Targeted Therapy Players
    Table 75. HER2 Targeted Therapy Market: Company Product Type Footprint
    Table 76. HER2 Targeted Therapy Market: Company Product Application Footprint
    Table 77. HER2 Targeted Therapy New Market Entrants and Barriers to Market Entry
    Table 78. HER2 Targeted Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 79. Global HER2 Targeted Therapy Consumption Value (USD Million) by Type (2019-2024)
    Table 80. Global HER2 Targeted Therapy Consumption Value Share by Type (2019-2024)
    Table 81. Global HER2 Targeted Therapy Consumption Value Forecast by Type (2025-2030)
    Table 82. Global HER2 Targeted Therapy Consumption Value by Application (2019-2024)
    Table 83. Global HER2 Targeted Therapy Consumption Value Forecast by Application (2025-2030)
    Table 84. North America HER2 Targeted Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 85. North America HER2 Targeted Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 86. North America HER2 Targeted Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 87. North America HER2 Targeted Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 88. North America HER2 Targeted Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 89. North America HER2 Targeted Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 90. Europe HER2 Targeted Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 91. Europe HER2 Targeted Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 92. Europe HER2 Targeted Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 93. Europe HER2 Targeted Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 94. Europe HER2 Targeted Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 95. Europe HER2 Targeted Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 96. Asia-Pacific HER2 Targeted Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 97. Asia-Pacific HER2 Targeted Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 98. Asia-Pacific HER2 Targeted Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 99. Asia-Pacific HER2 Targeted Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 100. Asia-Pacific HER2 Targeted Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 101. Asia-Pacific HER2 Targeted Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 102. South America HER2 Targeted Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 103. South America HER2 Targeted Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 104. South America HER2 Targeted Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 105. South America HER2 Targeted Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 106. South America HER2 Targeted Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 107. South America HER2 Targeted Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 108. Middle East & Africa HER2 Targeted Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 109. Middle East & Africa HER2 Targeted Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 110. Middle East & Africa HER2 Targeted Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 111. Middle East & Africa HER2 Targeted Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 112. Middle East & Africa HER2 Targeted Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 113. Middle East & Africa HER2 Targeted Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 114. HER2 Targeted Therapy Raw Material
    Table 115. Key Suppliers of HER2 Targeted Therapy Raw Materials
List of Figures
    Figure 1. HER2 Targeted Therapy Picture
    Figure 2. Global HER2 Targeted Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global HER2 Targeted Therapy Consumption Value Market Share by Type in 2023
    Figure 4. Monotherapy
    Figure 5. Combination Therapy
    Figure 6. Others
    Figure 7. Global HER2 Targeted Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. HER2 Targeted Therapy Consumption Value Market Share by Application in 2023
    Figure 9. Breast Cancer Picture
    Figure 10. Stomach Cancer Picture
    Figure 11. Head and Neck Cancer Picture
    Figure 12. Lung Cancer Picture
    Figure 13. Ovarian Cancer Picture
    Figure 14. Others Picture
    Figure 15. Global HER2 Targeted Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 16. Global HER2 Targeted Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 17. Global Market HER2 Targeted Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 18. Global HER2 Targeted Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 19. Global HER2 Targeted Therapy Consumption Value Market Share by Region in 2023
    Figure 20. North America HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. Europe HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. Asia-Pacific HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. South America HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 24. Middle East and Africa HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 25. Global HER2 Targeted Therapy Revenue Share by Players in 2023
    Figure 26. HER2 Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 27. Global Top 3 Players HER2 Targeted Therapy Market Share in 2023
    Figure 28. Global Top 6 Players HER2 Targeted Therapy Market Share in 2023
    Figure 29. Global HER2 Targeted Therapy Consumption Value Share by Type (2019-2024)
    Figure 30. Global HER2 Targeted Therapy Market Share Forecast by Type (2025-2030)
    Figure 31. Global HER2 Targeted Therapy Consumption Value Share by Application (2019-2024)
    Figure 32. Global HER2 Targeted Therapy Market Share Forecast by Application (2025-2030)
    Figure 33. North America HER2 Targeted Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 34. North America HER2 Targeted Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 35. North America HER2 Targeted Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 37. Canada HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 38. Mexico HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 39. Europe HER2 Targeted Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 40. Europe HER2 Targeted Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 41. Europe HER2 Targeted Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 42. Germany HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 43. France HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 44. United Kingdom HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 45. Russia HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 46. Italy HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 47. Asia-Pacific HER2 Targeted Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 48. Asia-Pacific HER2 Targeted Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 49. Asia-Pacific HER2 Targeted Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 50. China HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 51. Japan HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 52. South Korea HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 53. India HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 54. Southeast Asia HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 55. Australia HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 56. South America HER2 Targeted Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 57. South America HER2 Targeted Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 58. South America HER2 Targeted Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 59. Brazil HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 60. Argentina HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 61. Middle East and Africa HER2 Targeted Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 62. Middle East and Africa HER2 Targeted Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 63. Middle East and Africa HER2 Targeted Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 64. Turkey HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 65. Saudi Arabia HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 66. UAE HER2 Targeted Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 67. HER2 Targeted Therapy Market Drivers
    Figure 68. HER2 Targeted Therapy Market Restraints
    Figure 69. HER2 Targeted Therapy Market Trends
    Figure 70. Porters Five Forces Analysis
    Figure 71. Manufacturing Cost Structure Analysis of HER2 Targeted Therapy in 2023
    Figure 72. Manufacturing Process Analysis of HER2 Targeted Therapy
    Figure 73. HER2 Targeted Therapy Industrial Chain
    Figure 74. Methodology
    Figure 75. Research Process and Data Source

Companies Mentioned

GlaxoSmithKline
Bayer
Abbott
AbbVie
Pfizer
Sanofi
Agilent
Glenmark Pharmaceuticals
Merck
Roche
Novartis
Astra Zeneca
Daiichi Sankyo